A Fremont drug maker's stock tumbled 76% after the FDA dissed its kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in its approval… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

A Fremont drug maker's stock tumbled 76% after the FDA dissed its kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in its approval… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

East Bay drug maker tumbles 76% after FDA disses kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in the company's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

East Bay drug maker tumbles 76% after FDA disses kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in the company's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Hip fracture risk in elderly with non-end-stage chronic kidney disease: a fall related analysis - Covino M, Vitiello R, De Matteis G, Bonadia N, Piccioni A, Carbone L, Zaccaria R, Cauteruccio M, Ojetti V, Franceschi F.
BACKGROUND: The aim of this study was to evaluate the risk of fracture as a consequence of trauma and its association with kidney function status in a cohort of elderly patients. METHODS: This is an observational, cross-sectional study. We evaluate... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

FDA Panel Rejects Roxadustat for Anemia in Kidney Disease FDA Panel Rejects Roxadustat for Anemia in Kidney Disease
An FDA advisory committee voted by 1-13 and 2-12 margins against approving a novel, oral agent, roxadustat, for treating anemia in patients with chronic kidney disease. Safety was the major issue.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

Status on FDA Advisory Committee Vote on Roxadustat in Anemia of Chronic Kidney Disease
16 July 2021 -- The Food and Drug Administration’s (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted 13 to 1 that the benefit-risk profile of roxadustat does not support approval for the treatment of anemia in chronic... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 16, 2021 Category: Drugs & Pharmacology Source Type: news

New guidance on how to diagnosis and manage osteoporosis in chronic kidney disease
(International Osteoporosis Foundation) This new review by the International Osteoporosis Foundation (IOF) and European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) CKD-MBD working group provides concise recommendations, with a clear management algorithm, to support clinicians' knowledge and confidence in managing osteoporosis in their patients with chronic kidney disease stages 4-5D. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Iron Deficiency May Increase Mortality, CV Risks in Nondialysis CKD
WEDNESDAY, July 14, 2021 -- For patients with nondialysis chronic kidney disease (CKD), with or without anemia, iron deficiency as reflected by a serum biomarker of iron stores is associated with an increased risk for all-cause mortality and major... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2021 Category: Pharmaceuticals Source Type: news

Allocating COVID vaccines based on health and socioeconomic factors could cut mortality
(Columbia University's Mailman School of Public Health) An estimated 43 percent of variability in U.S. COVID-19 mortality is linked with county-level socioeconomic indicators and health vulnerabilities, with the strongest association seen in the proportions of people living with chronic kidney disease and living in nursing homes. The study by Columbia University Mailman School of Public Health researchers suggests that allocating vaccines based on these factors could help minimize severe outcomes, particularly deaths. Results are published in the open-access journal PLOS Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 13, 2021 Category: Infectious Diseases Source Type: news

Iron Therapy May Help More Patients With Kidney Disease Iron Therapy May Help More Patients With Kidney Disease
Treating iron deficiency in patients with chronic kidney disease but without anemia may reduce their risk of death, particularly from cardiovascular causes, new research hints.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
WHIPPANY, N.J.-- July 9, 2021 (BUSINESS WIRE)-- Bayer announced today the United States (U.S.) Food and Drug Administration (FDA) has approved Kerendia (finerenone), a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 9, 2021 Category: Drugs & Pharmacology Source Type: news

US-FDA-approves-finerenone-treatment-patients-chronic-kidney-disease-associated-2-diabetes
Finerenone is the first non-steroidal, selective mineralocorticoid receptor (MR) antagonist to demonstrate positive kidney and cardiovascular outcomes in patients with chronic kidney disease associated with type 2 diabetes / Despite guideline-directed therapies, many patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) still progress to loss of kidney function and are at high risk for cardiovascular events / By blocking MR overactivation, a key driver of CKD progression, finerenone works on a pathway largely unaddressed by existing treatments for CKD in T2D (Source: Bayer Company News)
Source: Bayer Company News - July 9, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Drug to Reduce Risk of Serious Kidney and Heart Complications in Adults with Chronic Kidney Disease Associated with Type 2 Diabetes
FDA has approved Kerendia (finerenone) tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death, non-fatal hearts attacks, and hospitalization for heart failure in adults with chronic kidney disease associated with type 2 diabetes. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 9, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Association of Positive Fluid Balance at Discharge After Sepsis Management With 30-Day Readmission
Conclusions and Relevance: In this large observational study of non–critically ill patients hospitalized with sepsis, there was no association between posi tive fluid balance at the time of discharge and readmission. However, these findings may have been limited by variable recording and documentation of fluid intake and output; additional studies are needed to examine the association of fluid status with outcomes in patients with sepsis to reduce read mission risk. This cohort study evaluates whether positive fluid balance among non–critically ill patients with sepsis was associated with increased readmission ...
Source: Current Awareness Service for Health (CASH) - July 9, 2021 Category: Consumer Health News Source Type: news

Why this anti-aging drug startup thinks it's barking up the right tree
Biotech's efforts to extend life through drugs is going to the dogs. A San Francisco startup, backed by Laura Deming's anti-aging Longevity Fund, plans to take its first drug into clinical trials soon, using an existing drug to target a cellular mechanism believed to be responsible for large and giant breed dogs aging faster than smaller dogs. A second drug, aimed at "doggy dementia" and chronic kidney disease, also is expected to start a study in dogs this year. Cellular Longevity Inc. — or… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 9, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Not So Crazy: Pancreas Transplants in Type 2 Diabetes Rising Not So Crazy: Pancreas Transplants in Type 2 Diabetes Rising
Simultaneous pancreas-kidney transplants are increasingly performed in patients with type 2 diabetes and chronic kidney disease, who now account for about 20% of all pancreas transplants in the US.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 8, 2021 Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news

The Role of Activin: The Other Side of CKD-MBD? The Role of Activin: The Other Side of CKD-MBD?
A new review explores the potential role of activin A in the development of mineral bone disorder in patients with chronic kidney disease.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

What Problems are Ciliopathies Associated With?
Discussion Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below. The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland. There are 3 subtypes: Infantile Occurs usually within 1 year of life Enlarged kidneys and severe hypertension In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Innovative Kidney Donor'Voucher' System Is Saving Lives
THURSDAY, June 24, 2021 -- In the world of chronic kidney disease, the dilemma is not uncommon: A relatively young patient with kidney trouble may need a transplant down the road, and an older family member is more than ready to step up. But the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 24, 2021 Category: General Medicine Source Type: news

Guidelines Updated for Managing BP in CKD Patients Not on Dialysis
TUESDAY, June 22, 2021 -- For patients with high blood pressure (BP) and chronic kidney disease (CKD) who are not receiving dialysis, a systolic BP of
Source: Drugs.com - Pharma News - June 22, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves SOAANZ for Edema Treatment in Patients with Heart Failure...
Soaanz offers an alternative treatment for heart failure patients with edema who skip a loop diuretic dose due to concerns with excessive urination, as well as patients with chronic kidney disease....(PRWeb June 21, 2021)Read the full story at https://www.prweb.com/releases/fda_approves_soaanz_for_edema_treatment_in_patients_with_heart_failure_and_renal_disease/prweb18013131.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 21, 2021 Category: Pharmaceuticals Source Type: news

A promising new target for urinary tract infections and kidney stones
(Tokyo Medical and Dental University) Researchers from Tokyo Medical and Dental University (TMDU) have found that the urinary secretion of uromodulin, a kidney-specific protein, can be increased by the hormone vasopressin via certain signaling pathways. Increasing the urinary secretion of uromodulin may protect against urinary tract infections and kidney stones, while the resulting lower uromodulin levels in kidney cells may help to prevent hypertension and chronic kidney disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2021 Category: International Medicine & Public Health Source Type: news

A Personalized Approach to CKD and Cardiovascular Disease A Personalized Approach to CKD and Cardiovascular Disease
Managing cardiovascular risk in patients with chronic kidney disease requires a collaborative approach.Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Study reveals COVID-19 risk factors for those with IDD
(Syracuse University) A study of nearly 550 adults with intellectual and developmental disabilities receiving residential services in New York City found that age, larger residential settings, Down syndrome and chronic kidney disease were the most common risk factors for COVID-19 diagnosis, and heart disease was most associated with COVID-19 deaths. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 14, 2021 Category: Infectious Diseases Source Type: news

Study shows high rates of kidney disease among adults with diabetes
(National University of Ireland Galway) Research carried out by academics at NUI Galway and clinicians at University Hospital Galway Diabetes Centre, involving more than 4,500 patients in the west of Ireland, suggests that, despite careful medical management, a relatively high proportion of people with diabetes in Ireland are developing chronic kidney disease over time and are at risk of kidney failure and other complications of poor kidney function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 13, 2021 Category: International Medicine & Public Health Source Type: news

Ultrasound can determine lung congestion in kidney patients
Ultrasound is a useful guide in determining lung congestion for hemodialysi...Read more on AuntMinnie.comRelated Reading: CT shows that acute kidney injury common among COVID-19 patients Shorter lung ultrasound exams can help kidney disease patients Ultrasound AI model can help evaluate chronic kidney disease Brain imaging with CT, MRI in kidney cancer patients finds metastases Exposure to contrast on CTPA doesn't cause long-term kidney injury (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 10, 2021 Category: Radiology Source Type: news

DDT COA #000119: PROMIS ® Pediatric Chronic Kidney Disease Short Form- Sleep Disturbance
DDT COA #000119: PROMIS ® Pediatric Chronic Kidney Disease Short Form- Sleep Disturbance (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 8, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

DDT COA #000095: PROMIS ® Pediatric Chronic Kidney Disease Short Form- Fatigue
DDT COA #000095: PROMIS ® Pediatric Chronic Kidney Disease Short Form- Fatigue (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 8, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Prediabetes Linked to Higher CVD and CKD Rates Prediabetes Linked to Higher CVD and CKD Rates
People with A1C levels short of frank type 2 diabetes still have an increased risk for atherosclerotic cardiovascular disease events and chronic kidney disease, new data from the UK Biobank database.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 3, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
CAMBRIDGE, Mass. and TOKYO, June 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, and its... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 1, 2021 Category: Drugs & Pharmacology Source Type: news

Efficacy and Safety of Gout Prophylaxis and Therapy in CKD Efficacy and Safety of Gout Prophylaxis and Therapy in CKD
Is gout flare prophylaxis and treatment a safe and effective therapeutic strategy for patients with underlying chronic kidney disease?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2021 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Ultrasound AI model can help evaluate chronic kidney disease
Artificial intelligence (AI)-based analysis of kidney ultrasound studies coul...Read more on AuntMinnie.comRelated Reading: Brain imaging with CT, MRI in kidney cancer patients finds metastases AI plus CT improves liver steatosis assessment CEUS helps predict chronic kidney disease progression Caution indicated with new GBCAs for kidney patients Prehydration not needed before contrast CT of kidneys (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 24, 2021 Category: Radiology Source Type: news

Colorado School of Public Health receives grant to address kidney disease among women in Guatemala
(University of Colorado Anschutz Medical Campus) The three-year K01 grant from the National Institute of Environmental Health Sciences will provides support to examine the environmental determinants of kidney injury in female sugarcane workers and female community members in Guatemala. The new study is part of CHWE's efforts to identify and prevent exposures that may contribute to the epidemic of chronic kidney disease of unknown origin (CKDu) in Central America. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 24, 2021 Category: International Medicine & Public Health Source Type: news

App Scans Medical Records to Find Those With Kidney Disease App Scans Medical Records to Find Those With Kidney Disease
A validated software algorithm can autonomously scan more than a million electronic medical records, identify people with chronic kidney disease, and diagnose their severity stage.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - May 21, 2021 Category: Transplant Surgery Tags: Nephrology News Source Type: news

How strengthening the biosimilar marketplace benefits patients
Biologics are medicines that are made from living organisms through highly complex manufacturing processes and include a wide variety of medicines such as therapeutic proteins, monoclonal antibodies and vaccines. They are used to prevent or treat a variety of diseases including cancer, chronic kidney disease, diabetes, cystic fibrosis and autoimmune disorders.  (Source: The Catalyst)
Source: The Catalyst - May 18, 2021 Category: Pharmaceuticals Tags: FDA Drug Cost Biologics and Biosimilars Source Type: news

Finerenone-potential-reduce-onset-atrial-fibrillation-flutter-patients-chronic-kidney-disease-2
A prespecified exploratory analysis of the FIDELIO-DKD study demonstrates that finerenone may significantly reduce the risk of new onset atrial fibrillation or flutter (AFF) in patients with CKD and T2D versus placebo when added to standard of care / This analysis also concluded that finerenone reduced the risk of kidney or cardiovascular events with no significant difference in the effect of finerenone between patients with and without history of AFF at baseline / Based on the comprehensive finerenone clinical trial program, finerenone is the first investigational non-steroidal, selective mineralocorticoid receptor (MR) a...
Source: Bayer Company News - May 17, 2021 Category: Pharmaceuticals Source Type: news

New AHA Statement on Aortic Stenosis in Chronic Kidney Disease New AHA Statement on Aortic Stenosis in Chronic Kidney Disease
Patients with chronic kidney disease and aortic stenosis have distinctive epidemiological and pathophysiological characteristics, presenting diagnostic and management challenges, a new statement says.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 13, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Risk factors for high fall risk in elderly patients with chronic kidney disease - Heybeli C, Kazancioglu R, Smith L, Veronese N, Soysal P.
PURPOSE: Patients with chronic kidney disease (CKD) usually represent an aging population, and both older age and CKD are associated with a higher risk of falling. Studies on risk factors among subjects with CKD are lacking. METHODS: Records of out... (Source: SafetyLit)
Source: SafetyLit - May 11, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Bayers-finerenone-meets-primary-endpoint-Phase-III-FIGARO-DKD-cardiovascular-outcomes-study-patients
Finerenone significantly reduced the composite primary endpoint of cardiovascular death and non-fatal cardiovascular events versus placebo when added to standard of care / Following the FIDELIO-DKD study, FIGARO-DKD is the second positive Phase III study within the finerenone study program in chronic kidney disease (CKD) and type 2 diabetes (T2D) to meet its primary endpoint / Patients with CKD and T2D are three times more likely to die from a cardiovascular-related cause than those with type 2 diabetes alone / Based on the comprehensive finerenone clinical trial program, finerenone is the first investigational non-steroid...
Source: Bayer Company News - May 10, 2021 Category: Pharmaceuticals Source Type: news

Removing Race Adjustment Could Up Prevalence of CKD in Blacks
FRIDAY, May 7, 2021 -- Removing the race adjustment from equations for estimated glomerular filtration rates (eGFRs) could result in a doubling of the prevalence of chronic kidney disease (CKD) among Black adults, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2021 Category: Pharmaceuticals Source Type: news

Failing Kidneys Could Bring Higher Dementia Risk
FRIDAY, May 7, 2021 -- Chronic kidney disease may carry an increased risk of dementia, according to a Swedish study. In people with chronic kidney disease, the bean-shaped organs gradually lose their ability to filter waste from the blood and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 7, 2021 Category: General Medicine Source Type: news

Farxiga Approved to Reduce Risk for CKD Progression
MONDAY, May 3, 2021 -- Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday. The drug is the first to be approved to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease
Based on results of the DAPA-CKD trial, the FDA has granted approval for the diabetes drug in patients with CKD at risk for disease progression.FDA Approvals (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 30, 2021 Category: Cardiology Tags: Nephrology News Alert Source Type: news

Farxiga Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression With and Without Type-2 Diabetes
30 April 2021 Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 30, 2021 Category: Drugs & Pharmacology Source Type: news

FDA Approves Treatment for Chronic Kidney Disease
Today, the FDA approved a treatment to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart failure in adults with chronic kidney disease who are at risk of disease progression. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 30, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Safety, Efficacy of Vadadustat Explored for CKD
THURSDAY, April 29, 2021 -- Vadadustat met the noninferiority criteria for cardiovascular safety versus darbepoetin alfa among patients with dialysis-dependent chronic kidney disease (DD-CKD), but not those with non-DD-CKD (NDD-CKD), according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2021 Category: Pharmaceuticals Source Type: news

Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain Vadadustat for Anemia in Chronic Kidney Disease: Questions Remain
The HIF prolyl hydroxylase inhibitor shows efficacy in the treatment of anemia with chronic kidney disease, but in non-dialysis patients increased cardiovascular risks are observed.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - April 28, 2021 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Dapagliflozin, Advanced Chronic Kidney Disease, and Mortality Dapagliflozin, Advanced Chronic Kidney Disease, and Mortality
A report on the effects of the SGLT2 inhibitor dapagliflozin on morbidity and mortality in patients with chronic kidney disease suggests these drugs have potential beyond their original use in T2DM.European Heart Journal (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 28, 2021 Category: Intensive Care Tags: Nephrology Journal Article Source Type: news

Algorithm scours electronic health records to reveal hidden kidney disease
(Columbia University Irving Medical Center) A new algorithm that taps data from a patient's electronic medical record can diagnose and stage chronic kidney disease, which is often undetected until it has caused irreversible damage. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 28, 2021 Category: International Medicine & Public Health Source Type: news